Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01042054
Other study ID # 09/S1102/17
Secondary ID 2009/R/SU/04
Status Completed
Phase N/A
First received January 4, 2010
Last updated March 12, 2015
Start date July 2009
Est. completion date July 2010

Study information

Verified date March 2015
Source University of Edinburgh
Contact n/a
Is FDA regulated No
Health authority United Kingdom: National Health Service
Study type Interventional

Clinical Trial Summary

The provision of adequate pain relief following major liver surgery is essential, not only for patient comfort, but for the prevention of complications, such as chest infection.

Commonly, pain relief in the first few days after surgery is provided by epidural analgesia. Drugs are delivered to the area around the spinal cord, through a fine plastic tube placed in the patients back, and this blocks sensation from the abdomen downwards, thereby providing effective pain relief without the need for opiate analgesia (e.g. morphine). Opiate analgesia can cause nausea, drowsiness and constipation, and its use should be minimised. Epidurals, however, can be associated with some problematic side effects. Low blood pressure is commonly encountered, and not only can its treatment be associated with complications, but patients are often confined to bed.

Mobility can also be limited if muscle function in the legs, (in addition to sensation), is inadvertently affected by the epidural drugs. Other problems associated with epidural use are the relatively common failure of the technique to provide adequate analgesia (20%), and some extremely rare but potentially disastrous complications of epidural insertion.

An alternative technique, is the provision of pain relief directly into the wound, via one or more multi−holed tubes(catheters), placed either in or close to the wound. This technique alone does not provide as effective analgesia as a functioning epidural, but when combined with other intravenous or oral analgesia, has been shown to be effective following a variety of surgical procedures.

It is hypothesised that, following major liver surgery, the use of this latter technique may result in superior outcome and faster recovery, when compared with epidural, by avoidance of the side effects and complications discussed above.

In this study, patients scheduled to undergo major liver surgery at the Royal Infirmary of Edinburgh with be randomly assigned to receive the first two days of pain relief either by epidural, or by wound catheter plus additional analgesia. Both groups will then receive an identical oral analgesic regime for the remainder of the hospital stay.

Outcomes of interest will include the quality of pain relief attained, patient mobility, frequency of complications, and overall recovery time.


Recruitment information / eligibility

Status Completed
Enrollment 65
Est. completion date July 2010
Est. primary completion date July 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients undergoing open hepatic resection for benign or malignant conditions.

- Able to understand the nature of the study and what will be required of them.

- Men and non-pregnant, non-lactating women.

- BMI 18-40.

Exclusion Criteria:

- Patients with contraindication to either epidural or wound catheter techniques.

- Inability to give written, informed consent.

- Patients with dementia or neurological impairment.

- Patients with pre-existing condition limiting mobility.

- Underlying cirrhotic liver disease.

- Jaundice (Bilirubin > 50 µmol/L).

- Liver resection combined with secondary surgical procedure.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Standard optimised recovery protocol.
Epidural analgesia for the first 48 hours postoperatively. Sham wound catheter attached to anterior abdominal wall, for purposes of blinding. Standard oral analgesic regime commenced at 48 hours, and continued until discharge from hospital. Optimised recovery protocol followed throughout.
Wound catheter plus patient-controlled analgesia.
Continuous infusion of local anaesthetic administered via wound catheters for the first 48 hours postoperatively. Additional patient-controlled intravenous opiate analgesia available to patient during this time period. Sham epidural catheter applied to the patient's back for purposes of blinding. Standard oral analgesic regime commenced at 48 hours, and continued until discharge from hospital. Optimised recovery protocol followed throughout.

Locations

Country Name City State
United Kingdom Department of Surgery, Royal Infirmary of Edinburgh Edinburgh Midlothian

Sponsors (2)

Lead Sponsor Collaborator
University of Edinburgh NHS Lothian

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Length of time to reach criteria for discharge from hospital. This will be assessed twice daily until criteria for dicharge from hospital are met. No
Secondary Pain scores, assessed using numerical rating score (0 to 10). Assessed at 2, 6 & 12 hours following closure of wound, and daily thereafter until discharge from hospital, or day 7, whichever is sooner. No
Secondary Nausea and sedation scores, assessed using numerical rating score (0 to 3). Assessed at 2, 6 & 12 hours following closure of wound, and daily thereafter until discharge from hospital, or day 7, whicever is sooner. No
Secondary Sleep disturbance, assessed using numerical rating score (0 to 10). Assessed daily from the morning following surgery until discharge from hospital, or day 7, whichever is sooner. No
Secondary Volume of intravenous fluids received in the first 48 hours following operation (ml). Data collected daily for first 48 hours following operation. No
Secondary Mobility (percentage of time spent lying / sitting, standing or walking, as measured by ActivPAL meter). From the end of the operative procedure until discharge from hospital, or day 7, whichever is sooner. No
Secondary Time to return of bowel function (days). Assessed daily until return of bowel function. No
Secondary Length of time to meet criteria for discharge from the High Dependency Unit. Assessed twice daily until criteria for discharge from the High Dependency Unit met. No
Secondary Complications (General and Technical). Assessed daily throughout hospital admission, and at outpatient review clinic 4-6 weeks following discharge from hospital. Yes
See also
  Status Clinical Trial Phase
Completed NCT04633850 - Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
Recruiting NCT03181620 - Sedation Administration Timing: Intermittent Dosing Reduces Time to Extubation N/A
Completed NCT04579354 - Virtual Reality (VR) Tour to Reduce Preoperative Anxiety Before Anaesthesia N/A
Recruiting NCT06007378 - Optimizing Postoperative Pain Control After Laparoscopic Colorectal Surgery N/A
Recruiting NCT05943015 - Analgesic Efficacy of Quadratus Lumborum, Paravertebral Blocks N/A
Completed NCT04544228 - Ketamine or Neostigmine for Serratus Anterior Plane Block in Modified Radical Mastectomy N/A
Completed NCT03678168 - A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries N/A
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Completed NCT03663478 - Continuous TQL Block for Elective Cesarean Section Phase 4
Completed NCT04176822 - Designing Animated Movie for Preoperative Period N/A
Completed NCT05170477 - Influence of Apical Patency Concept Upon Postoperative Pain After Root Canal Treatment N/A
Not yet recruiting NCT04561856 - Fascia Iliaca Block Supplemented With Perineural Vs Intravenous Dexamethasone Phase 4
Completed NCT06425601 - A Comparison of Silicone Versus Polyvinylchloride (PVC) Drains Following VATS Lobectomy N/A
Completed NCT03612947 - TAP Block in Laparoscopic Cholecystectomy. Phase 2
Completed NCT05974501 - Pre vs Post Block in Total Knee Arthroplasty (TKA) Phase 4
Completed NCT05995912 - Efficacy and Safety of Etoricoxib-tramadol Tablet in Acute Postoperative Pain Phase 2
Completed NCT04571515 - Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain Phase 2
Active, not recruiting NCT04190355 - The Effect of Irrigant Types Used During Endodontic Treatment on Postoperative Pain N/A
Recruiting NCT05145153 - Incidence of Chronic Pain After Thoracic Surgery
Recruiting NCT03697278 - Monitoring Postoperative Patient-controlled Analgesia (PCA) N/A